Future studies with glia- and neuron-specific promoters are needed to fully characterize the cell-autonomous and non-cell-autonomous mechanisms underlying the neuroinflammation and epilepsy phenotype identified in Depdc5-knockout models. This evidence concerns the gene DEPDC5 and epilepsy.